SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
5.14
0.00 (0.00%)
Aug 13, 2025, 4:00 PM - Market closed
SciSparc Employees
SciSparc had 2 employees as of December 31, 2024. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
$653,000
Profits / Employee
-$3,142,000
Market Cap
2.75M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SPRC News
- 7 days ago - SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar - GlobeNewsWire
- 14 days ago - SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC - GlobeNewsWire
- 15 days ago - SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease - GlobeNewsWire
- 23 days ago - SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification - GlobeNewsWire
- 7 weeks ago - SciSparc Announces 1-for-21 Reverse Share Split - GlobeNewsWire
- 2 months ago - SciSparc Announces Publication of Japanese Patent Application - GlobeNewsWire
- 3 months ago - SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders - GlobeNewsWire
- 5 months ago - SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers - GlobeNewsWire